Evidence map›Paper›PMID 27478842›Full record

Trial reportBioMed research international2016

Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study.

Markus Loibl, Siegmund Lang, Lena-Marie Dendl, Michael Nerlich, Peter Angele, Sebastian Gehmert, Michaela Huber

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Regenerative Therapies for Basal Thumb Arthritis-A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Platelet-Rich Plasma in Plastic Surgery: A Systematic Review.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2022
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Platelet-Rich Plasma Injection for Thumb Carpometacarpal Joint Osteoarthritis.Archives of rehabilitation research and clinical translation · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Osteoarthritis year in review 2017: clinical.Osteoarthritis and cartilage · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Markus LoiblDepartment of Trauma Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-7631-0476
Siegmund LangDepartment of Trauma Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.
Lena-Marie DendlInstitute of Radiology, University Medical Center Regensburg, 93053 Regensburg, Germany.
Michael NerlichDepartment of Trauma Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.
Peter AngeleDepartment of Trauma Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.
Sebastian GehmertDepartment of Orthopedic Surgery, University Hospital Basel, 4056 Basel, Switzerland.
Michaela HuberDepartment of Trauma Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-7478-5697
University Hospital Regensburg · DEUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of 1.47 ± 0.25 mL PRP was injected at the first injection and 1.5 ± 0.41 mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from 6.2 ± 1.6 to 5.4 ± 2.2 at six-month follow-up (P < 0.05). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from 46.5 ± 18.6 to 67.5 ± 19.0 at six-month follow-up (P = 0.05). Grip was unaffected, whereas pinch declined from 6.02 ± 2.99 to 3.96 ± 1.77 at six-month follow-up (P < 0.05). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.

Indexed as

AgedArthritisFemaleHumansJointsLeukocytesMaleMiddle AgedPain MeasurementPilot ProjectsPinch StrengthPlatelet-Rich PlasmaThumbTreatment OutcomeWrist

Identifiers

PMID27478842
PMCPMC4949344
OpenAlexW2468197636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.